53 min

Episode #149 High Truths on Drugs and Addiction with Dr Jennifer Triemstra and FDA approved cannabinoid research High Truths on Drugs and Addiction

    • Health & Fitness

Cannabis has many different chemicals, namely cannabinoids that have pharmaceutical benefits. Learn about FDA approved cannabinoid research.  There is a big difference between medications that are FDA approved and smoking weed.



Jennifer Triemstra, MS PhD

Jennifer L Triemstra, MS, PhD – Associate Medical Director – Cannabinoid Education, US Medical Affairs, Jazz Pharmaceuticals
 Jennifer, also known as, “Trie”, is an Associate Director in Medical Affairs for Jazz Pharmaceuticals, leading the Cannabinoid Science Education program.  Trie has been working in the cannabinoid science space for nearly 7 years and was instrumental in building the content for CannabinoidClinical.com educational website and leads the Cannabinoid Education Working Group.  Trie has presented to learners across the United States including scientific and healthcare providers, advocacy groups, medical societies, state government and policy making members, and beyond the US including the UN Commission on Narcotic Drugs.  Prior to her current role, Trie was a Medical Science Liaison at Greenwich Biosciences, US subsidiary of GW Pharmaceuticals, providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy.  Trie received her Master of Science in Cellular and Molecular Biology from Saint Cloud State University and her PhD in Comparative and Molecular Biosciences at the University of Minnesota, School of Veterinary Medicine.  Before graduate school, she spent several years working in academia performing laboratory research focused on neuroendocrinology.

Cannabis has many different chemicals, namely cannabinoids that have pharmaceutical benefits. Learn about FDA approved cannabinoid research.  There is a big difference between medications that are FDA approved and smoking weed.



Jennifer Triemstra, MS PhD

Jennifer L Triemstra, MS, PhD – Associate Medical Director – Cannabinoid Education, US Medical Affairs, Jazz Pharmaceuticals
 Jennifer, also known as, “Trie”, is an Associate Director in Medical Affairs for Jazz Pharmaceuticals, leading the Cannabinoid Science Education program.  Trie has been working in the cannabinoid science space for nearly 7 years and was instrumental in building the content for CannabinoidClinical.com educational website and leads the Cannabinoid Education Working Group.  Trie has presented to learners across the United States including scientific and healthcare providers, advocacy groups, medical societies, state government and policy making members, and beyond the US including the UN Commission on Narcotic Drugs.  Prior to her current role, Trie was a Medical Science Liaison at Greenwich Biosciences, US subsidiary of GW Pharmaceuticals, providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy.  Trie received her Master of Science in Cellular and Molecular Biology from Saint Cloud State University and her PhD in Comparative and Molecular Biosciences at the University of Minnesota, School of Veterinary Medicine.  Before graduate school, she spent several years working in academia performing laboratory research focused on neuroendocrinology.

53 min

Top Podcasts In Health & Fitness

Scicomm Media
Ramsey Network
iHeartPodcasts
John R. Miles
Peter Attia, MD
Mari Llewellyn